Monica Prasad-Hayes, MD
- ASSOCIATE PROFESSOR | Obstetrics, Gynecology and Reproductive Science
Research Topics:Cancer, Cancer Genetics
Monica Prasad Hayes, MD is in the Faculty Practice in the Division of Gynecologic Oncology. Dr. Prasad Hayes graduated from Cornell University and obtained her medical degree from SUNY Upstate Medical University at Syracuse where she was inducted as a member of the Alpha Omega Alpha Honor Medical Society. She completed her residency in Obstetrics and Gynecology at New York Presbyterian Hospital/Weill Cornell Medical Center and then went on to complete a research fellowship in the Department of Surgery at Memorial Sloan Kettering Cancer Center focusing on the molecular genetics of endometrial cancer. She then completed a fellowship in Gynecologic Oncology at The Mount Sinai Medical Center.
Dr. Prasad Hayes practices Gynecologic Oncology and Gynecologic Surgery including robotic and minimally invasive surgery. She is currently the institutional Principal Investigator for The Mount Sinai Medical Center in the Gynecologic Oncology Group, one of the National Cancer Institute's (NCI) funded cooperative cancer research groups. She has a particular interest in hereditary gynecologic cancer and molecular genetic alterations in gynecologic cancer, as well as in clinical trial design utilizing novel therapeutic agents.
Obstetrics & Gynecology
- Cervical Cancer
- Cervical Conization
- Cervical Dysplasia
- Dilation And Curettage
- Exploratory Laparotomy
- Heavy Menstrual Bleeding
- Loop Electrosurgical Excision Procedure
- Lymph Node Biopsy
- Lysis Of Adhesions
- Ovarian Cancer
- Ovarian Cyst
- Ovarian Cyst Removal
- Robot-Assisted Laparoscopic Procedures
- Sentinel Lymph Node Biopsy
- Small Bowel Obstruction
- Small Bowel Resection
- Uterine Cancer
- Uterine Fibroids
- Vaginal Cancer
- Wound Dehiscence
MD, SUNY Upstate Medical Center
Weill Cornell Medical Center
Memorial Sloan-Kettering Cancer Center
Residency, Ob-Gyn, New York Presbyterian - Weill Cornell Medical Center
Fellowship, Gynecology Oncology, Mount Sinai Hospital
Castle Connolly Top Doctor
Distinguished Housestaff Award
Chief Administrative Resident
Berlex Laboratories Best PGY-2 Resident Teaching Award
Robert E. Nesbitt Award in Obstetrics and Gynecology
Alpha Omega Alpha Honor Medical Society, Inducted 1996
- A Randomized Phase II/III Study of Paclitaxel/Carboplatin/Metformin (NSC#91485) Versus Paclitaxel/Carboplatin/Placebo as Initial Therapy for Measurable Stage III or IVA, Stage IVB, or Recurrent Endometrial Cancer (GOG0286B)
The primary objective is to determine if the addition of metformin to the standard regimen of carboplatin and paclitaxel prolongs progression-free survival (PFS) in women with advanced or recurrent endometrial cancer (Phase II). To determine if the addition of metformin ...
- A Phase 3 Randomized, Double-blind, Placebo-controlled, Multicenter Study of AMG 386 With Paclitaxel and Carboplatin as First-line Treatment of Subjects With FIGO Stage III-IV Epithelial Ovarian, Primary Peritoneal or Fallopian Tube Cancers
The purpose of this study is to find out more about an experimental drug called AMG 386 in people with advanced epithelial ovarian, primary peritoneal or fallopian tube cancers. The purpose of this research is to see if the treatment with paclitaxel and carboplatin (approved c...
Hayes MP, Douglas W, Ellenson LH. Molecular alterations of EGFR and PIK3CA in uterine serous carcinoma. Gynecologic Oncology 2009 June; 113(3): 370-373.
Nezhat F, Prasad Hayes M, Peiretti M, Rahaman J. Laparoscopic radical parametrectomy and partial vaginectomy for recurrent endometrial cancer. Gynecologic Oncology 2007 February; 104(2): 494-496.
Hayes MP, Wang H, Espinal-Witter R, Douglas W, Solomon G, Ellenson LH. PIK3CA and PTEN mutations in uterine endometrioid carcinoma and complex atypical hyperplasia. Clinical Cancer Research 2006 October; 12(20 Pt 1): 5932-5935.
Prasad M, Wang H, Douglas W, Barakat RR, Ellenson LH. Molecular genetic characterization of tamoxifen-associated endometrial cancer. Gynecologic Oncology 2005 January; 96(1): 25-31.
Prasad M, Ben-Porat L, Hoppe B, Aghajanian C, Sabbatini P, Chi DS, Hensley ML. Costs of treatment and outcomes associated with second-line therapy and greater for relapsed ovarian cancer. Gynecologic Oncology 2004 April; 93(1): 223-228.
Husain A, Chi D, Prasad M, Abu-Rustum NR, Barakat R, Brown CL, Poynor EA, Hoskins WJ, Curtin JP. The role of laparoscopy in second-look evaluations for ovarian cancer. Gynecologic Oncology 2001 January; 80(1): 44-47.
Sills ES, Schattman GL, Veeck LL, Liu HC, Prasad M, Rosenwaks Z. Characteristics of consecutive in vitro fertilization cycles among patients treated with follicle-stimulating hormone (FSH) and human menopausal gonadotropin versus FSH alone. Fertility and Sterility 1998 May; 69(5): 831-835.
Badawy SW, Prasad M, Powers C, Wojtowycz AR. Congenital cervicovaginal aplasia with septate uterus and functioning endometrium. Journal of Pediatric & Adolescent Gynecology 1997 November; 10(4): 213-217.
Fong Y, Cohen AM, Fortner JG, Enker WE, Turnbull AD, Coit DG, Marrero AM, Prasad M, Blumgart LH, Brennan MF. Liver resection for colorectal metastases. Journal of Clinical Oncology 1997 March; 15(3): 938-946.
Howell EA, Egorova N, Hayes MP, Wisnivesky J, Franco R, Bickell N. Racial disparities in the treatment of advanced epithelial ovarian cancer. Obstetrics and gynecology 2013 Nov; 122(5).